Class IITerminated in FDA datasetMay 15, 2019

Immuno PRP Spray

Recalling firm: APS BioGroup, Inc

Why it was recalled

The recall is being conducted as a result of elevated APC levels. Through additional testing, it was determined that the organism is Stenotrophomonas maltophilia.

Check your package

Compare the exact product and package details with the label you have.

ProductImmuno PRP Spray, UPC 8 12527 01176 2. Colostrum Polypeptides. 5 fl oz (140 mL)
UPC812527011762

FDA code information

Manufactured April 21, 2019. Lot 9068-2, Item # 4044, Bulk # UL-7, Exp. Date 04/2021; Lot 9068-3, Item # 4691, Bulk # UL-7, Exp. Date 04/2021; Lot 9068-4, Item # 4181, Bulk # UL-7, Exp. Date 04/2021; Lot 9068-5, Item # 00064, Bulk # UL-7, Exp. Date 04/2021; Lot 9068-6, Item # 00064, Bulk # UL-7, Exp. Date 04/2021

Match the product, package size, and code together. A missing match does not guarantee safety.

Full FDA record and distribution details

Original product description

Immuno PRP Spray, UPC 8 12527 01176 2. Colostrum Polypeptides. 5 fl oz (140 mL)

Extracted codes and context

TypeCode / valueContext
UPC812527011762Immuno PRP Spray, UPC 8 12527 01176 2. Colostrum Polypeptides. 5 fl oz (140 mL)

Recall details

Recall number
F-1478-2019
Event ID
82900
FDA status
Terminated
Initiated
May 15, 2019
Reported
Jun 26, 2019
Classified
Jun 18, 2019
Terminated
Dec 27, 2019
Quantity
7,132 Total Units
Location
Phoenix, AZ, United States
Initiation type
Voluntary: Firm initiated
Notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Where it was distributed

Nationwide and Switzerland. No military/govt/VA consignees.

FDA source record · F-1478-2019

Data updated September 16, 2026. View official FDA data ↗

Follow official FDA and manufacturer guidance.